Cargando…

Development and Evaluation of an Antiviral Agent Medication Adherence Education Program for Patients with Chronic Hepatitis C

This study aimed to develop and evaluate a goal attainment theory-based antiviral agent medication adherence education program (AMAEP) for patients with chronic hepatitis C. A nonequivalent control group pretest-posttest design was used. Data were collected from December 2019 to March 2020 from a co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hoo Jeung, Park, Euna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558411/ https://www.ncbi.nlm.nih.gov/pubmed/32906842 http://dx.doi.org/10.3390/ijerph17186518

Ejemplares similares

Illness Experience of Patients with Chronic Hepatitis C Participating in Clinical Trials
por: Cho, Hoo-Jeung, et al.
Publicado: (2016)

Quality of Life of Chronic Hepatitis C Patients and Its Associated Factors
por: Cho, Hoo Jeung, et al.
Publicado: (2017)

Canonical Correlation Between Self-Care Agency and Health-Related Self-Efficacy with Chronic Viral Hepatitis Patients
por: Cho, HooJeung, et al.
Publicado: (2019)

New Antiviral Agents for Hepatitis C
por: Pawlotsky, Jean-Michel
Publicado: (2012)

Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents
por: Estefan, Sergio, et al.
Publicado: (2021)

Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
por: Kanda, Tatsuo, et al.
Publicado: (2014)

Challenges in the discontinuation of chronic hepatitis B antiviral agents
por: Kaewdech, Apichat, et al.
Publicado: (2021)

Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients
por: El-Mahdy, Nageh Ahmed, et al.
Publicado: (2023)

Hepatitis C Screening and Treatment Program in Hungarian Prisons in the Era of Direct Acting Antiviral Agents
por: Werling, Klára, et al.
Publicado: (2022)

Glycyrrhizin as antiviral agent against Hepatitis C Virus
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Hypozincemia in Chronic Hepatitis C Is Improved with Viral Clearance by Direct-acting Antiviral Agents
por: Shirahashi, Ryosaku, et al.
Publicado: (2021)

The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection
por: Dawood, Reham M, et al.
Publicado: (2022)

Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
por: Xu, Kerui, et al.
Publicado: (2018)

The care cascade for hepatitis C virus and prognosis of chronic hepatitis C patients treated with antiviral agents in a tertiary hospital
por: Yoo, Sung Hwan, et al.
Publicado: (2023)

Role of Direct Antiviral Agents in Treatment of Chronic Hepatitis C Infection in Renal Transplant Recipients
por: Sharma, Sourabh, et al.
Publicado: (2018)

Recurrent hyperkalemia in patients with chronic kidney disease and hepatitis C treated with direct antiviral agents
por: Yan, Taotao, et al.
Publicado: (2019)

Hepatitis C and renal transplantation in era of new antiviral agents
por: Salvadori, Maurizio, et al.
Publicado: (2018)

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)

New era for management of chronic hepatitis C virus using direct antiviral agents: A review
por: Elbaz, Tamer, et al.
Publicado: (2015)

Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients
por: Cheng, Chun-Han, et al.
Publicado: (2022)

Evaluation of fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
por: Tufan, Ayse Gokcen, et al.
Publicado: (2020)

Hepatitis C-related membranoproliferative glomerulonephritis in the era of direct antiviral agents
por: Abdelhamid, Walid Ahmed Ragab, et al.
Publicado: (2021)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
por: Wang, Yadong, et al.
Publicado: (2022)

Recent Advances in Antiviral Therapy for Chronic Hepatitis C
por: Tamori, Akihiro, et al.
Publicado: (2016)

Use of antiviral therapy in patients with chronic hepatitis C
por: Dragomiretskaya, Natalia, et al.
Publicado: (2015)

Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents
por: Gualerzi, Alessandro, et al.
Publicado: (2018)

Incidence and predictors for abnormal liver function during direct-acting antiviral agents in chronic hepatitis C patients
por: Liu, Yen-Chun, et al.
Publicado: (2020)

Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents
por: Chen, Yen-Chun, et al.
Publicado: (2020)

Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agents in Patients with Hepatitis C
por: Turcu-Stiolica, Adina, et al.
Publicado: (2021)

Real-world Effectiveness and Safety of Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C Genotype 2 Infection: Korean Multicenter Study
por: Kang, Yeo Wool, et al.
Publicado: (2021)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
por: Toshikuni, Nobuyuki
Publicado: (2017)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents
por: Ghweil, Ali A, et al.
Publicado: (2019)

Eczema craquelé associated with antiviral treatment for chronic hepatitis C
por: do Vale, Edla Polsinelli Bedin Mascarin, et al.
Publicado: (2017)

Liver-related effects of chronic hepatitis C antiviral treatment
por: Laursen, Tea L, et al.
Publicado: (2020)

Knowledge and Attitude Related to Hepatitis C among Medical Students in the Oral Direct Acting Antiviral Agents Era in Vietnam
por: Pham, Thi Thanh Hang, et al.
Publicado: (2022)

Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era
por: Poovorawan, Kittiyod, et al.
Publicado: (2016)

Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients
por: Juanbeltz, Regina, et al.
Publicado: (2018)

Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus Infection
por: Ko, Yi-Ling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_90jc6mn5dt434d9uca4l9f69b1